A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors
Sandhu, Shahneen K., Papadopoulos, Kyri, Fong, Peter C., Patnaik, Amita, Messiou, Christina, Olmos, David, Wang, George, Tromp, Brenda J., Puchalski, Thomas A., Balkwill, Frances, Berns, Birge, Seetharam, Shobha, de Bono, Johann S., Tolcher, Anthony W.
Published in Cancer chemotherapy and pharmacology (01.04.2013)
Published in Cancer chemotherapy and pharmacology (01.04.2013)
Get full text
Journal Article
Phase I and Pharmacokinetic Study of XRP6258 (RPR 116258A), a Novel Taxane, Administered as a 1-Hour Infusion Every 3 Weeks in Patients with Advanced Solid Tumors
MITA, Alain C, DENIS, Louis J, SEMIOND, Dorothée, BESENVAL, Michèle, TOLCHER, Anthony W, ROWINSKY, Eric K, DEBONO, Johann S, GOETZ, Andrew D, OCHOA, Leonel, FOROUZESH, Bahram, BEERAM, Muralidhar, PATNAIK, Amita, MOLPUS, Kathleen
Published in Clinical cancer research (15.01.2009)
Published in Clinical cancer research (15.01.2009)
Get full text
Journal Article
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2- and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
Bardia, Aditya, Krop, Ian E, Kogawa, Takahiro, Juric, Dejan, Tolcher, Anthony W, Hamilton, Erika P, Mukohara, Toru, Lisberg, Aaron, Shimizu, Toshio, Spira, Alexander I, Tsurutani, Junji, Damodaran, Senthil, Papadopoulos, Kyriakos P, Greenberg, Jonathan, Kobayashi, Fumiaki, Zebger-Gong, Hong, Wong, Rie, Kawasaki, Yui, Nakamura, Tadakatsu, Meric-Bernstam, Funda
Published in Journal of clinical oncology (01.07.2024)
Published in Journal of clinical oncology (01.07.2024)
Get full text
Journal Article
Phase I study of the MEK inhibitor trametinib in combination with the AKT inhibitor afuresertib in patients with solid tumors and multiple myeloma
Tolcher, Anthony W., Patnaik, Amita, Papadopoulos, Kyriakos P., Rasco, Drew W., Becerra, Carlos R., Allred, Alicia J., Orford, Keith, Aktan, Gursel, Ferron-Brady, Geraldine, Ibrahim, Nageatte, Gauvin, Jennifer, Motwani, Monica, Cornfeld, Mark
Published in Cancer chemotherapy and pharmacology (01.01.2015)
Published in Cancer chemotherapy and pharmacology (01.01.2015)
Get full text
Journal Article
Phase I and Pharmacokinetic Study of YM155, a Small-Molecule Inhibitor of Survivin
TOLCHER, Anthony W, MITA, Alain, KEATING, Anne, ANTONIA, Scott, LEWIS, Lionel D, GARRETT, Christopher R, TILL, Elizabeth, DAUD, Adil I, PATNAIK, Amita, PAPADOPOULOS, Kyri, TAKIMOTO, Chris, BARTELS, Pamela
Published in Journal of clinical oncology (10.11.2008)
Published in Journal of clinical oncology (10.11.2008)
Get full text
Journal Article
A Phase I Study of ASTX660, an Antagonist of Inhibitors of Apoptosis Proteins, in Adults with Advanced Cancers or Lymphoma
Mita, Monica M, LoRusso, Patricia M, Papadopoulos, Kyriakos P, Gordon, Michael S, Mita, Alain C, Ferraldeschi, Roberta, Keer, Harold, Oganesian, Aram, Su, Xiang Yao, Jueliger, Simone, Tolcher, Anthony W
Published in Clinical cancer research (15.06.2020)
Published in Clinical cancer research (15.06.2020)
Get full text
Journal Article
Phase II Study of Ganitumab, a Fully Human Anti–Type-1 Insulin-Like Growth Factor Receptor Antibody, in Patients With Metastatic Ewing Family Tumors or Desmoplastic Small Round Cell Tumors
TAP, William D, DEMETRI, George, LEITCH, Ian, BADOLA, Sunita, SUNG CHANG, MIN ZHU, TOLCHER, Anthony, BARNETTE, Phillip, DESAI, Jayesh, KAVAN, Petr, TOZER, Richard, BENEDETTO, Pasquale W, FRIBERG, Gregory, HONGJIE DENG, MCCAFFERY, Ian
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
A phase 1 study of anti-TGFβ receptor type-II monoclonal antibody LY3022859 in patients with advanced solid tumors
Tolcher, Anthony W., Berlin, Jordan D., Cosaert, Jan, Kauh, John, Chan, Emily, Piha-Paul, Sarina A., Amaya, Alex, Tang, Shande, Driscoll, Kyla, Kimbung, Richard, Kambhampati, S. R. Prasad, Gueorguieva, Ivelina, Hong, David S.
Published in Cancer chemotherapy and pharmacology (01.04.2017)
Published in Cancer chemotherapy and pharmacology (01.04.2017)
Get full text
Journal Article
Genome and transcriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnerabilities
Craig, David W, O'Shaughnessy, Joyce A, Kiefer, Jeffrey A, Aldrich, Jessica, Sinari, Shripad, Moses, Tracy M, Wong, Shukmei, Dinh, Jennifer, Christoforides, Alexis, Blum, Joanne L, Aitelli, Cristi L, Osborne, Cynthia R, Izatt, Tyler, Kurdoglu, Ahmet, Baker, Angela, Koeman, Julie, Barbacioru, Catalin, Sakarya, Onur, De La Vega, Francisco M, Siddiqui, Asim, Hoang, Linh, Billings, Paul R, Salhia, Bodour, Tolcher, Anthony W, Trent, Jeffrey M, Mousses, Spyro, Von Hoff, Daniel, Carpten, John D
Published in Molecular cancer therapeutics (01.01.2013)
Published in Molecular cancer therapeutics (01.01.2013)
Get full text
Journal Article
Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245409 (XL765), a Novel, Orally Administered PI3K/mTOR Inhibitor in Patients with Advanced Solid Tumors
PAPADOPOULOS, Kyriakos P, TABERNERO, Josep, MILES, Dale, LORUSSO, Patricia M, MARKMAN, Ben, PATNAIK, Amita, TOLCHER, Anthony W, BASELGA, José, WEILIANG SHI, EGILE, Coumaran, RUIZ-SOTO, Rodrigo, LAIRD, A. Douglas
Published in Clinical cancer research (01.05.2014)
Published in Clinical cancer research (01.05.2014)
Get full text
Journal Article
Phase I Pharmacokinetic and Biologic Correlative Study of Mapatumumab, a Fully Human Monoclonal Antibody With Agonist Activity to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Receptor-1
TOLCHER, Anthony W, MITA, Monica, HALPERN, Wendy, COREY, Alfred, COHEN, Roger B, MEROPOL, Neal J, VON MEHREN, Margaret, PATNAIK, Amita, PADAVIC, Kristin, HILL, Monique, MAYS, Theresa, MCCOY, Therese, FOX, Norma Lynn
Published in Journal of clinical oncology (10.04.2007)
Published in Journal of clinical oncology (10.04.2007)
Get full text
Journal Article
A First-in-Human Phase I Study of the Oral p38 MAPK Inhibitor, Ralimetinib (LY2228820 Dimesylate), in Patients with Advanced Cancer
Patnaik, Amita, Haluska, Paul, Tolcher, Anthony W, Erlichman, Charles, Papadopoulos, Kyriakos P, Lensing, Janet L, Beeram, Muralidhar, Molina, Julian R, Rasco, Drew W, Arcos, Rebecca R, Kelly, Claudia S, Wijayawardana, Sameera R, Zhang, Xuekui, Stancato, Louis F, Bell, Robert, Shi, Peipei, Kulanthaivel, Palaniappan, Pitou, Celine, Mulle, Lynette B, Farrington, Daphne L, Chan, Edward M, Goetz, Matthew P
Published in Clinical cancer research (01.03.2016)
Published in Clinical cancer research (01.03.2016)
Get full text
Journal Article
Phase I Trial of the Novel Mammalian Target of Rapamycin Inhibitor Deforolimus (AP23573; MK-8669) Administered Intravenously Daily for 5 Days Every 2 Weeks to Patients With Advanced Malignancies
MITA, Monica M, MITA, Alain C, KNOWLES, Heather, RIVERA, Victor M, KREISBERG, Jeff, BEDROSIAN, Camille L, TOLCHER, Anthony W, CHU, Quincy S, ROWINSKY, Eric K, FETTERLY, Gerald J, GOLDSTON, Michelle, PATNAIK, Amita, MATHEWS, Lesley, RICART, Alejandro D, MAYS, Theresa
Published in Journal of clinical oncology (20.01.2008)
Published in Journal of clinical oncology (20.01.2008)
Get full text
Journal Article
Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial
Blay, Jean-Yves, Prof, Pápai, Zsuzsanna, MD, Tolcher, Anthony W, Prof, Italiano, Antoine, MD, Cupissol, Didier, MD, López-Pousa, Antonio, MD, Chawla, Sant P, Bompas, Emmanuelle, MD, Babovic, Nada, MD, Penel, Nicolas, MD, Isambert, Nicolas, MD, Staddon, Arthur P, MD, Saâda-Bouzid, Esma, MD, Santoro, Armando, MD, Franke, Fabio A, MD, Cohen, Patrick, MD, Le-Guennec, Solenn, Demetri, George D, Prof
Published in The lancet oncology (01.05.2015)
Published in The lancet oncology (01.05.2015)
Get full text
Journal Article
A phase I, dose-escalation study of PF-06650808, an anti-Notch3 antibody–drug conjugate, in patients with breast cancer and other advanced solid tumors
Rosen, Lee S., Wesolowski, Robert, Baffa, Raffaele, Liao, Kai-Hsin, Hua, Steven Y., Gibson, Brenda L., Pirie-Shepherd, Steven, Tolcher, Anthony W.
Published in Investigational new drugs (01.02.2020)
Published in Investigational new drugs (01.02.2020)
Get full text
Journal Article
Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors
Molife, L Rhoda, Yan, Li, Vitfell-Rasmussen, Joanna, Zernhelt, Adriane M, Sullivan, Daniel M, Cassier, Philippe A, Chen, Eric, Biondo, Andrea, Tetteh, Ernestina, Siu, Lillian L, Patnaik, Amita, Papadopoulos, Kyriakos P, de Bono, Johann S, Tolcher, Anthony W, Minton, Susan
Published in Journal of hematology and oncology (03.01.2014)
Published in Journal of hematology and oncology (03.01.2014)
Get full text
Journal Article
Phase I study of the CD40 agonist antibody CP-870,893 combined with carboplatin and paclitaxel in patients with advanced solid tumors
Vonderheide, Robert H., Burg, Jennifer M., Mick, Rosemarie, Trosko, Jennifer A., Li, Dongguang, Shaik, M. Naveed, Tolcher, Anthony W., Hamid, Omid
Published in Oncoimmunology (01.01.2013)
Published in Oncoimmunology (01.01.2013)
Get full text
Journal Article
Phase I dose-escalation trial of the oral AKT inhibitor uprosertib in combination with the oral MEK1/MEK2 inhibitor trametinib in patients with solid tumors
Tolcher, Anthony W., Kurzrock, Razelle, Valero, Vincente, Gonzalez, Rene, Heist, Rebecca S., Tan, Antoinette R., Means-Powell, Julie, Werner, Theresa L., Becerra, Carlos, Wang, Chenxi, Leonowens, Cathrine, Kalyana-Sundaram, Shanker, Kleha, Joseph F., Gauvin, Jennifer, D’Amelio, Anthony M., Ellis, Catherine, Ibrahim, Nageatte, Yan, Li
Published in Cancer chemotherapy and pharmacology (01.04.2020)
Published in Cancer chemotherapy and pharmacology (01.04.2020)
Get full text
Journal Article